iSpinach: a fluorogenic RNA aptamer optimized for in vitro applications
Autour A, Westhof E, Ryckelynck M.
Nucleic Acids Res. 2016 Mar 1.
Interview with Maire Fiona Osborn, Ph.D.
Maire Fiona Osborn, Ph.D. Postdoctoral Associate, RNA Therapeutics Institute University of Massachusetts Medical School How did you become interested in the field of oligonucleotides? I took a somewhat circuitous route to the field of
Deletion of exons 3-9 encompassing a mutational hot spot in the DMD gene presents an asymptomatic phenotype, indicating a target region for multiexon skipping therapy
Nakamura A, Fueki N, Shiba N, Motoki H, Miyazaki D, Nishizawa H, Echigoya Y, Yokota T, Aoki Y, Takeda S.
J Hum Genet. 2016 Mar 24.
Enhancing homology-directed genome editing by catalytically active and inactive CRISPR-Cas9 using asymmetric donor DNA
Richardson CD, Ray GJ, DeWitt MA, Curie GL, Corn JE.
Nat Biotechnol. 2016 Mar;34(3):339-44.